Supplementary benefits of CT-guided transthoracic lung aspiration biopsy for core needle biopsy

Jiahuan He, Jia-Xing Ruan, Lei Ying, Zhidan Hua, Xiang Chen, Da Huang, Chengshui Chen, Xuru JinFrontiers in Microbiology 2022 · DOI

TL;DR

Combining core needle biopsy (CNB) with aspiration biopsy (AB) under CT guidance significantly boosts the diagnostic accuracy of lung lesions from 90% to 98%. While CNB remains the gold standard for identifying malignancy, AB acts as a critical "microbiological safety net," catching hidden infections like tuberculosis that histology alone often misses.

What Problem Does This Paper Address?

When a physician spots a suspicious mass in a patient's lung via CT scan, the immediate question is: Is it cancer, or is it an infection? Standard practice usually involves a Core Needle Biopsy (CNB), which removes a small "chunk" of tissue for histological examination. While excellent for identifying tumor architecture, CNB often fails to capture the pathogens responsible for infections like tuberculosis (TB) or fungal diseases.

Conversely, Aspiration Biopsy (AB) uses a finer needle to "suck out" cells and fluid. This "liquid" sample is better suited for microbiology and cytology but lacks the structural detail of a core sample. The researchers sought to quantify the "supplementary benefit" of performing both procedures sequentially. Specifically, they wanted to see if the combined approach could reduce false negatives for cancer and improve the detection of complex co-infections.

Methods

The researchers conducted a retrospective study of 1,085 patients who underwent sequential CT-guided CNB and AB on the same lung lesion.

  • The Procedure: Under CT guidance, a coaxial needle was used to first perform the core biopsy (cutting tissue). Immediately after, a syringe was used to aspirate fluid/cells through the same sheath.
  • Pathology: Samples were processed for both histopathology (CNB) and cell wax cytology (AB).
  • Microbiology: Aspirates were subjected to advanced testing, including GenXpert MTB/RIF (a rapid molecular test for TB) and BD BACTEC cultures for mycobacteria and fungi.
  • Comparison: The team compared the diagnostic yield of CNB alone, AB alone, and the two methods combined.

Datasets

The study utilized a clinical dataset of 1,085 patients treated at the First Affiliated Hospital of Wenzhou Medical University between January 2016 and January 2021. The dataset included:

  • Electronic medical records and CT imaging.
  • Pathological results from 1,085 pairs of cutting and aspiration samples.
  • Microbiological data from 511 cases highly suspected of infection.

Key Insights and Ideas

  • The "Aha" Moment for Co-infection: One of the most striking findings was that malignancy and infection are not mutually exclusive. In 3.1% of cases where a malignant tumor was found, the aspirate also identified a concurrent infection (like TB or Aspergillus). CNB alone would likely have missed these, leaving the patient's infection untreated during chemotherapy.
  • Microbiological Superiority of Aspiration: For infectious lesions, AB was nearly twice as effective as CNB (47.4% vs. 22.8% diagnostic rate). The "soup" obtained by aspiration is simply a better medium for molecular and culture-based pathogen detection than a solid tissue fragment.
  • Reducing the "Insufficient Sample" Rate: By using both methods, the rate of "insufficient specimens" (samples that yield no diagnosis) dropped from ~10–14% for either method alone to just 2%.
  • Safety Profile: Despite performing two types of biopsy, the complication rates (like pneumothorax or minor bleeding) remained within standard ranges, suggesting the combined approach is safe for routine clinical use.

Key Results

  • Overall Diagnostic Rate: The combined approach reached 98%, significantly higher than CNB (90.1%) or AB (86.3%) alone.
  • Malignancy Detection: Adding AB to the CNB workflow reduced the false-negative rate for malignant lesions from 11.8% down to 5.6%.
  • Tuberculosis (TB) Sensitivity: TB is notoriously difficult to diagnose. CNB alone had a sensitivity of only 27.8%. When combined with AB, GenXpert, and culture, the sensitivity skyrocketed to 90%.
  • Pathogen Identification: In 232 infectious cases, the combined parallel diagnostic rate for pathogens reached 64.7%, providing a much clearer roadmap for antibiotic or antifungal treatment.

Limitations and Future Work

  • Retrospective Nature: As a retrospective study from a single center, the results may be influenced by local institutional expertise and patient demographics.
  • Operator Dependency: The success of CT-guided biopsies is highly dependent on the skill of the interventional radiologist, which was not a variable controlled in this study.
  • Bleeding Assessment: The authors noted they did not formally grade the severity of local bleeding on CT images, which could be a factor in sample quality.
  • Future Directions: The authors suggest that future work should focus on prospective, multi-center trials to standardize this combined "cutting + aspiration" protocol as a clinical benchmark for lung lesion diagnosis.

Summary updated

Abstract

CT-guided lung aspiration biopsy has a significant supplementary effect on core needle biopsies, which is indispensable in clinical application. Additionally, the combination of aspiration biopsy and core needle biopsy can significantly improve the diagnostic rate of benign and malignant lesions. Aspiration biopsy showed that pulmonary malignant lesions are complicated with pulmonary tuberculosis, aspergillus, and other infections. Finally, the diagnostic ability of lung puncture core needle biopsy and aspiration biopsy combined with routine microbial detection under CT positioning in the diagnosis of pulmonary infectious diseases was significantly improved.
BibTeX
@inproceedings{he2022supplementary,
  author = {Jiahuan He and Jia-Xing Ruan and Lei Ying and Zhidan Hua and Xiang Chen and Da Huang and Chengshui Chen and Xuru Jin},
  title = {{Supplementary benefits of CT-guided transthoracic lung aspiration biopsy for core needle biopsy}},
  booktitle = {Frontiers in Microbiology},
  year = {2022},
  doi = {10.3389/fmicb.2022.1005241},
}
Figure